Drug-Related Hospital Admissions and Associated Factors among Adults Admitted to Felege Hiwot Comprehensive and Specialized Hospital, North West Ethiopia
Table 7
Associated factors with DRHAs among patients admitted to Felege Hiwot Comprehensive Specialized Hospital medical ward from July to September 15, 2020.
Variables
COR (95% CI)
AOR (95% CI)
value
Yes
No
Area of residence
Rural
84
209
0.62 (0.041–0.96)
1.06 (0.58–1.91)
0.844
Urban
51
79
1
1
Health insurance
Yes
63
157
1
1
No
72
131
1.36(0.9–2.06)
1.86 (1.06–3.25)
0.028
Chronic kidney disease
0.436
No CKD
112
268
1
1
CKD
18
14
3.07 (1.49–6.40)
1.67 (0.40–6.83)
0.474
ESRD
5
6
1.99(0.57–6.68)
2.58 (0.54–12.23)
0.231
HIV status
0.102
On ART
17
13
2.91 (1.32–6.45)
6.56 (1.13–37.92)
0.035
Unknown
66
159
0.92 (0.59–1.43)
0.97 (0.54–1.744)
0.941
Tested negative
52
116
1
1
Number of drugs
0.271
1-2 drugs
44
23
14.73 (7.83–27.70)
3.09 (0.71–13.45)
0.131
≥3
61
34
13.81 (7.84–24.33)
3.08 (0.76–12.33)
0.112
None
30
231
1
1
Charlson comorbidity index score
0.001
None
5
88
1
1
1–2
81
147
9.69 (3.8–24.85)
6.82 (2.39–19.46)
0.0001
3–5
29
28
18.22 (6.44–51.57)
5.29 (1.55–17.99)
0.008
≥6
20
25
14.08(4.8° -41.29)
1.02 (0.16–6.24)
0.979
Duration of pharmacotherapy
0.032
<1 years
22
17
10.26 (4.89–21.54)
3.23 (0.69–15.15)
0.136
1–3 years
43
16
21.31 (10.67–42.5)
7.45 (1.75–31.67)
0.006
>4 years
41
25
13.0 (6.92–24.4)
3.87 (0.92–16.2)
0.064
None
29
230
1
1
CKD: chronic kidney disease, ESRD: end-stage renal disease, ART: anti-retroviral therapy, HIV: human immune virus, : value <0.05, : value <0.001.
